Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data

Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data

Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data · Investor's Business Daily

Shares in Alterity Therapeutics soared after the biotech firm disclosed promising new clinical trial data for its Parkinson's disease treatment.